研究室について
研究紹介
研究業績
イベント

研究業績

査読有の欧文学術論文 (計94編, うち筆頭22編と責任5編，Impact Factor (IF); 2021年データ)

  1. Muranaka Y, Matsue M, Mizutani A, Kobayashi M, Sato K, Kondo A, Nishiyama Y, Ohata S, Nishi K, Yamazaki K, Nishii R, Shikano N, Okamoto S, Kawai K. Evaluation of L-Alanine metabolism in bacteria for nuclear medicine imaging of bacterial infection. Int J Mol Sci. 2023;24(5):4775.IF=6.208
  2. Sato K, Mizutani A, Muranaka Y, Yao J, Kobayashi M, Yamazaki K, Nishii R, Nishi K, Nakanishi T, Tamai I, Kawai K. Biological distribution after oral administration of radioiodine-labeled acetaminophen to estimate gastrointestinal absorption function via OATPs, OATs and/or MRPs. Pharmaceutics. 2023;15(2):497. IF=6.525
  3. Sato K, Seki T, Mizutani A, Muranaka Y, Hirota S, Nishi K, Yamazaki K, Nishii K, Nakanishi T, Tamai I, Kawai K. Kobayashi M. A single high-dose irradiation changes accumulation of methotrexate and gene expression levels of SLC and ABC transporters in cancer cells. Front. Pharmacol. 2023:13:1069321. IF=5.988
  4. Mizutani A, Kobayashi M, Aibe R, Muranaka Y, Nishi K, Kitamura M, Suzuki C, Nishii R, Shikano N, Magata Y, Ishida Y, Kunishima M, Kawai K. Measurement of Hepatic CYP3A4 and 2D6 Activity Using Radioiodine-Labeled O-Desmethylvenlafaxine. Int J Mol Sci. 2022;23(19):11458. IF=6.208
  5. Yamazaki K, Nishii R, Mizutani Y, Makishima H, Kaneko T, Isobe Y, Terada T, Tamura K, Tani T, Kobayashi M, Wakamatsu M, Tsuji H, Higashi T. Estimation of post-therapeutic liver reserve capacity using 99mTc-GSA Scintigraphy prior to carbon-ion radiotherapy for liver tumors. European Journal of Nuclear Medicine and Molecular Imaging. 2022. doi: 10.1007/s00259-022-05985-5. IF=10.057
  6. Muranaka Y, Mizutani A, Kobayashi M, Nakamoto K, Matsue M, Takagi F, Okazaki K, Nishi K, Yamazaki K, Nishii R, Shikano N, Okamoto S, Maki H, Kawai K. 123I-BMIPP, a radiopharmaceutical for myocardial fatty acid metabolism scintigraphy, could be utilized in bacterial infection imaging. Pharmaceutics. 2022;14(5):1008. IF=6.525
  7. Mizutani A, Kobayashi M, Ohuchi M, Sasaki K, Muranaka Y, Torikai Y, Fukakusa S, Suzuki C, Nishii R, Haruta S, Magata Y, Kawai K. Indirect SPECT imaging evaluation for possible nose-to-brain drug delivery using a compound with poor blood-brain barrier permeability in mice. Pharmaceutics. 2022;14(5):1026. IF=6.525
  8. Muranaka Y, Mizutani A, Kobayashi M, Nakamoto K, Matsue M, Nishi K, Yamazaki K, Nishii R, Shikano N, Okamoto S, Kawai K. Comparison of L- and D-Amino acids for Bacterial Imaging at Lung Infection Mouse Model. Int J Mol Sci. 2022;23(5):2467. IF=6.208
  9. Kobayashi M, Mizutani A, Muranaka Y, Nishi K, Komori H, Nishii R, Shikano N, Nakanishi T, Tamai I, Kawai. K. Biological distribution of orally administrated [123I]MIBG for estimation of gastrointestinal tract absorption. Pharmaceutics. 2021;14(1):61. doi: 10.3390/pharmaceutics14010061. IF=6.525
  10. Nishi K, Kobayashi M, Kikuchi M, Mizutani A, Muranaka Y, Tamai I, Kawai K, Kudo T. Inhibition of the hepatic uptake of 99mTc-tetrofosmin using an organic cation transporter blocker. Pharmaceutics. 2021;13(7):1073. IF=6.525
  11. Rong-Hua T, Kobayashi M, Yang Y, Kleinerman E. Exercise inhibits Doxorubicin-induced damage to cardiac vessels and activation of Hippo/YAP-mediated apoptosis. Cancers(Basel). 2021;13(11):2740. IF=6.575
  12. Suga M, Nishii R, Miwa K, Kamitaka Y, Yamazaki K, Tamura K, Yamamoto N, Kohno R, Kobayashi M, Tanimoto K, Tsuji H, Higashi T. Differentiation between non-small cell lung cancer and radiation pneumonitis after carbon-ion radiotherapy by 18F-FDG PET/CT texture analysis. Sci Rep. 2021;11(1):11509. IF=4.379
  13. Kobayashi M, Mizutani A, Okamoto T, Muranaka Y, Nishi K, Nishii R, Shikano N, Nakanishi T, Tamai I, Kleinerman ES, Kawai K. Assessment of drug transporters involved in the urinary secretion of [99mTc]dimercaptosuccinic acid. Nucl Med Biol. 2021;94-95:92-7. IF=2.408
  14. Nishii R, Saga T, Sudo H, Togawa T, Kuyama J, Tani T, Maeda T, Kobayashi M, Iizasa T, Shingyoji M, Itami M, Kawamura K, Hashimoto H, Yamazaki K, Tamura K, Higashi T. Clinical Value of PET/CT with Carbon-11 4DST in the Evaluation of malignant and benign lung tumors. Ann Nucl Med. 2021;35(2):211-22. IF=2.668
  15. Kobayashi M, Mizutani A, Nishi K, Muranaka Y, Nishii R, Shikano N, Nakanishi T, Tamai I, Kleinerman ES, Kawai K. [131I]MIBG exports via MRP transporters and inhibition of the MRP transporters improves accumulation of [131I]MIBG in neuroblastoma. Nucl Med Biol. 2020;90-91:49-54. IF=2.408
  16. Kobayashi M, Nishi K, Mizutani A, Okudaira H, Nakanishi T, Shikano N, Nishii R, Tamai I, Kawai K. Transport mechanism and affinity of [99mTc]mercaptoacetyltriglycine ([99mTc]MAG3) on the apical membrane of renal proximal tubule cells. Nucl Med Biol. 2020;84-85:33-7. IF=2.408
  17. Kobayashi M, Nishi K, Mizutani A, Hokama T, Matsue M, Tsujikawa T, Nakanishi T, Nishii R, Tamai I, Kawai  K. Imaging of hepatic drug transporters with [131I]6-β-iodomethyl-19-norcholesterol. Sci Rep. 2019; 9(1):13413. IF=4.379
  18. Mukai K, Ogai K, Kobayashi M, Ueda T, Nakajima Y, Nakatani T. Longitudinal investigation of Propioni-bacterium acnes burden and skin physiological function during menstruation in healthy women. Structure and Function. 2019;18(1):20-30. IF=0.000
  19. Kobayashi M, Kato T, Washiyama K, Ihara M, Mizutani A, Nishi K, Flores LG 2nd, Nishii R, Kawai K. The pharmacological properties of 3-arm or 4-arm DOTA constructs for conjugation to a-melanocyte-stimulating hormone analogues for melanoma imaging. PLoS One. 2019;14(3):e0213397. IF=3.240
  20. Aoki M, Ogai K, Matsumoto M, Susa H, Yamada K, Yamatake T, Kobayashi M, Sugama J. Comparison of wiping methods for the removal of cleaning agent residue from hair follicles. Skin Res Technol. 2019;25(3):355-8. IF=2.365
  21. Aoki M, Ogai K, Kobayashi M, Minematsu T, Nakatani T, Okuwa M, Sanada H, Sugama J. Comparison of ceramide kinetics in the stratum corneum between dry skin and normal skin using animal models with fluorescent imaging method. Skin Res Technol. 2019;25(2):158-64. IF=2.365
  22. Shikano N, Yagi N, Nishii R, Ohe K, Nakajima S, Ogura M, Ikeda A, Kobayashi M, Yamaguchi N, Kawai K. Radioiodinated 6-iodo-D-meta-tyrosine: characterization of uptake in DLD-1 colon cancer cells and biodistribution in mice. ASVIP. 2019; 24:1-11. IF=0.000
  23. Shikano N, Yagi N, Nishii R, Nakajima S, Ogura M, Ikeda A, Kobayashi M, Yamaguchi N, Kawai K. Implications for the use of 6-radioiodinated L-meta-tyrosine as a tumor imaging agent: mouse biodistribution, renal autoradiography, and colon cancer DLD-1 cell studies. ASVIP. 2019;24:13-21. IF=0.000
  24. Kobayashi M, Tsujiuchi T, Mizutani A, Nishi K, Nakanishi T, Nishii R, Fukuchi K, Tamai I, Kawai K. Different efflux transporter affinity and metabolism of 99mTc-2-methoxyisobutylisonitrile and 99mTc-tetrofosmin for multidrug resistance monitoring in cancer. Pharm Res. 2018;36(1):18. IF=4.580
  25. Shrestha S, Singh P, Cortes-Salva MY, Jenko KJ, Ikawa M, Kim MJ, Kobayashi M, Morse CL, Zoghbi SS, Gladding RL, Fujita M, Innis RB, Pike VW. 1,2,4-Triazole-based Compounds as PET Radioligands for Imaging Brain COX-1 in Monkey. Part 2: Selection and Evaluation of [11C]PS13 for Quantitative Imaging. ACS Chem Neurosci. 2018;9(11):2620-7. IF=4.418
  26. Mizutani A, Kobayashi M, Fujita KI, Takahashi K, Hokama T, Takasu H, Nishi K, Nishii R, Shikano N, Fukuchi K, Kawai K. 123I-iomazenil whole-body imaging to detect hepatic carboxylesterase drug metabolizing enzyme activity. Nucl Med Commun.2018;39(9):825-33. IF=1.690
  27. Iuchi T, Tsuchiya S, Sato A, Dai M, Imran I, Kobayashi M, Sugama J. The changes of chronic leg oedema after recumbent position at night in chair-bound elderly Japanese individuals. Lymphoedema Research and Practice. 2018;6(1):1-9. IF=0.000
  28. Nishii R, Higashi T, Kagawa S, Arimoto M, Kishibe Y, Takahashi M, Yamada, Saiki M, Arakawa Y, Yamauchi H, Okuyama C, Hojo M, Munemitsu T, Sawada M, Kobayashi M, Kawai K, Nagamachi S, Hirai T, Miyamoto S. Diagnosis of brain tumors using system A amino acid transport PET imaging with C-11-MeAIB: A comparison study with C-11-methionine PET imaging. Contrast Media Mol Imaging. 2018;2018:1292746.. IF=3.161
  29. Tsujikawa T, Tsuyoshi H, Kanno M, Yamada S, Kobayashi M, Narita T, Kimura H, Fujieda S, Yoshida Y, Okazawa H. SelectedPET radiomic features remain the same. Oncotarget. 2018;9(29):20734-46. IF=0.000
  30. Matsumoto M, Ogai K, Aoki M, Urai T, Yokogawa M, Tawara M, Kobayashi M, Minematsu T, Sanada H, Sugama J. Changes in dermal structure and skin oxidative stress in overweight and obese Japanese males after weight loss: a longitudinal observation study. Skin Res Technolo. 2018;24(3):407-16. IF=2.365
  31. Zhu WJ, Kobayashi M, Yamada K, Mizutani A, Nishi K, Shikano N, Nishii R, Kunishima M, Kawai K. Development of radioiodine-labeled acetaminophen for specific, high-contrast imaging of malignant melanoma. Nucl Med Biol. 2018;59:16-21. IF=2.408
  32. Matsumoto M, Ogai K, Ohashi R, Tanaka K, Aoki M, Kobayashi M, Sugama J. Influences of different methods of cleaning agent removal on the effectiveness of skin dirt removal. The Society for Nursing Science and Engineering. 2018;5(1):22-30. IF=0.000
  33. Kobayashi M, Jiang T, Telu S, Zoghhi SS, Gunn R, Rabiner EA, Owen DR, Guo Q, Pike VW, Innis RB, Fujita M. 11C-DPA-713 has much greater specific binding to translocator protein 18 kDa (TSPO) in human brain than does 11C-(R)-PK11195. J Cereb Blood Flow Metab. 2018;38(3):393-403. IF=6.200
  34. Shikano N, Kusanagi K, Ogura M, Nakajima S, Serizawa Y, Hamai Y, Matsutani S, Kobayashi M, Kawai K.  Basic Study on Atherosclerosis Imaging: The Effect of Foam-cell Formation on S-[methyl-14C]-D/L-methionine Uptake by THP-1–derived Macrophages. ASVIP. 2018;23:1-8. IF=0.000
  35. Shikano N, Kusanagi K, Ogura M, Nakajima S, Serizawa Y, Hamai Y, Matsutani S, Kobayashi M, Kawai K, Shimokado K. Increased D-[S-methyl-14C]-methionine after co-loading of L-tyrosine ethyl ester in C6 glioma cells. ASVIP. 2018; 23: 9-16. IF=0.000
  36. Fujita M, Kobayashi M, Ikawa M, Gunn RN, Rabiner EA, Owen DR, Zoghbi SS, Haskali MB, Telu S, Pike VW, Innis RB. Comparison of four 11C-labeled PET ligands to quantify translocator protein 18 kDa (TSPO) in human brain: (R)-PK11195, PBR28, DPA-713, and ER176. EJNMMI Research. 2017;7:84. IF=3.138
  37. Iuchi T, Kobayashi M, Tsuchiya S, Ohno N, Dai M, Matsumoto M, Ogai K, Sato A, Sawazaki T, Miyati T, Tanaka S, Sugama J. Objective assessment of leg edema using ultrasonography with a gel pad. PLoS One. 2017;12:e0182042. IF=3.240
  38. Mukai K, Zhu WJ, Nakajima Y, Kobayashi M, Nakatani T. Non-invasive longitudinal monitoring of the angiogenesis in a murine excisional cutaneous wound healing model using a high-resolution three-dimensional ultrasound imaging. Skin Res Technolo. 2017;23:581-7. IF=2.365
  39. Ogai K, Matsumoto M, Aoki M, Ota R, Hashimoto K, Wada R, Kobayashi M, Sugama J. Wash or wipe? A comparative study of skin physiological changes between water washing and wiping after skin cleaning. Skin Res Technolo. 2017;23:519-24. IF=2.365
  40. Kagawa S, Nishii R, Higashi T, Yamaguchi H, Ogawa E, Okudaira H, Kobayashi M, Yoshimoto M, Shikano N, Kawai K. Relationship between [14C]MeAIB uptake and amino acid transporter family gene expression levels or proliferative activity in human carcinoma cells: comparison with [3H]Methionine uptake. Nucl Med Biol. 2017;49:8-15. IF=2.408
  41. Ono M, Barden A, Okudaira H, Kobayashi M, Kawai K, Oka S, Yoshimura H. Assessment of amino acid/drug transporters for renal transport of [18F]fluciclovine (anti-[18F]FACBC) in vitro. Int J Mol Sci. 2017;17(10): pii:E1730. IF=5.923
  42. Kobayashi M, Mizutani A, Nishi K, Nakajima S, Shikano N, Nishii R, Fukuchi K, Kawai K. Difference in accumulation and the transport mechanism of L- and D-methionine in high- and low-grade human glioma cells. Nucl Med Biol. 2017;44:78-82. IF=2.408
  43. Ogai K, Matsumoto M, Aoki M, Minematsu T, Kitamura K, Kobayashi M, Sanada H, Sugama J. Increased level of tumor necrosis factor-alpha (TNF-α) on the skin of Japanese obese males: measured by quantitative skin blotting. Int Journal Cosmet Sci. 2016;38(5):462-9. IF=2.970
  44. Kobayashi M, Matsunari I, Nishi K, Mizutani A, Miyazaki Y, Ogai K, Sugama J, Shiba K, Kawai K, Kinuya S. Stimultaneous acquisition of 99mTc and 123I-labeled radiotracers using a preclinical SPECT scanner with CZT detectors. Ann Nucl Med. 2016;30(4):263-71. IF=2.668
  45. Ono M, Oka S, Okudaira H, Nakanishi T, Mizokami A, Kobayashi M, Schuster DM, Goodman MM, Shirakami Y, Kawai K. [14C]Fluciclovine (alias anti-[14C]FACBC) uptake and ASCT2 expression in castration-resistant prostate cancer cells. Nucl Med Biol. 2015;42(11):887-92. IF=2.408
  46. Mizutani A, Matsunari I, Kobayashi M, Nishi K, Fujita W, Miyazaki Y, Nekolla SG, Kawai K. Impact of injection dose, post-reconstruction filtering, and collimator choice on image quality of myocardial perfusion SPECT using cadmium-zinc telluride detectors in the rat. EJNMMI Physics. 2015;2(1):7. IF=3.309
  47. Kobayashi M, Mori T, Tsujikawa T, Mizutani A, Ogai K, Sugama J, Kiyono Y, Kawai K, Okazawa H. Comparison of image quality with 62Cu and 64Cu-labeled radiotracers in Positron Emission Tomography whole-body phantom imaging. Hell J Nucl Med. 2015;18(2):103-7. IF=1.102
  48. Kobayashi M, Nishii R, Shikano N, Florens LG 2nd, Mizutani A, Ogai K, Sugama J, Nagamachi S, Kawai K. Development of radioiodine-labeled 4-hydroxyphenylcysteamine for specific diagnosis of malignant melanoma. Nucl Med Biol. 2015;42(6):536-40. IF=2.408
  49. Ogura M, Shikano N, Nakajima S, Sagara J, Yamaguchi N, Kusanagi K, Okui Y, Mizutani A, Kobayashi M, Kawai K. A strategy for improving FDG accumulation for early detection of metastasis for primary pancreatic cancer: stimulation of the Warburg effect in AsPC-1 cells. Nucl Med Biol. 2015;42(5):475-81. IF=2.408
  50. Ogai K, Matsumoto M, Minematsu T, Kitamura K, Kobayashi M, Sugama J, Sanada H. Development of an improved method for quantitative analysis of skin blotting: increasing reliability and applicability for skin assessment. Int J Cosmet Sci.2015;37(4):425-32. IF=2.970
  51. Nishi K, Mizutani A, Shikano N, Fujita K, Kobayashi M, Ono M, Nishii R, Sasaki Y, Kinuya S, Kawai K. In vivo radioactive metabolism analysis for individualized medicine: a basic study of a new method of CYP activity assay using 123I-IMP. Nucl Med Biol. 2014;42(2):171-6. IF=2.408
  52. Okudaira H, Oka S, Ono M, Nakanishi T, Shuster DM, Kobayashi M, Goodman MM, Tamai I, Kawai K, Shirakami Y. Accumulation of trans-1-amino-3-18F-fluorocyclobutanecarboxylic acid in prostate cancer due to androgen-induced expression of amino-acid transporters. Mol Imaging Biol. 2014;16(6):756-64. IF=3.488
  53. Kobayashi M, Wakabayashi H, Kayano D, Konishi T, Kojima H, Okuda K, Yoneyama H, Tsushima H, Onoguchi M, Kawai K, Kinuya S. Application of a medium-energy collimator for I-131 imaging after ablation treatment of differentiated thyroid cancer. Ann Nucl Med. 2014;28(6):551-8. IF=2.668
  54. Miyazaki Y, Kobayashi M, Komatsu R, Hayashi A, Yonezawa S, Kawai K, Matsudaira M, Shiozaki J, Matsunari I. Effect of surrounding materials on iterative reconstruction based spatial resolution, and annihilations outside the source assessed by a small animal PET scanner. Ann Nucl Med. 2014;28(6):512-22. IF=2.668
  55. Matsunari I, Miyazaki Y, Kobayashi M, Nishi K, Mizutani A, Kawai K, Hayashi A, Komatsu R, Yonezawa R, Kinuya S. Performance evaluation of the eXplore speCZT preclinical imaging system. Ann Nucl Med. 2014;28(6):484-97. IF=2.668
  56. Kobayashi M, Nakanishi T, Nishi K, Higaki Y, Okudaira H, Ono M, Tsujiuchi T, Mizutani A, Nishii R, Tamai I, Arano Y, Kawai K. Transport mechanism of hepatic uptake and bile excretion in clinical hepatobiliary scintigraphy with 99mTc-N-pyridoxyl-5-methyltryptophan. Nucl Med Biol. 2014;41(4):338-42. IF=2.408
  57. Yoneyama H, Tsushima H, Kobayashi M, Onoguchi M, Nakajima K, Kinuya S. Improved detection of sentinel lymph nodes in SPECT/CT images acquired using a low-medium-energy-general-purpose (LMEGP) collimator. Clin Nucl Med. 2014;39(1):e1-6. IF=7.794
  58. Kobayashi M, Wakabayashi H, Kojima H, Konishi T, Okuda K, Yoneyama H, Kayano D,　Tobisaka H, Tsushima H, Onoguchi M, Kawai K, Kinuya S. Prototype imaging protocols for monitoring the efficacy of iodine-131 ablation in differentiated thyroid cancer. Hell J Nucl Med. 2013;16(3):175-80. IF=1.102
  59. Nishii R, Higashi T, Kagawa S, Kishibe Y, Takahashi M, Yamauchi H, Motoyama H, Kawakami K, Nakaoku T, Nohara J, Okamura M, Watanabe T, Nakatani K, Nagamachi S, Tamura S, Kawai K, Kobayashi M. Clinical evaluation of an amino acid tracer, α-[N-methyl-11C]-methylaminoisobutyric acid ([11C]MeAIB), in the oncologic PET diagnosis of chest malignancies. Ann Nucl Med. 2013;27(9):808-21. IF=2.668
  60. Okudaira H, Nakanishi T, Oka S, Kobayashi M, Tamagami H, Schuster DM, Goodman MM, Shirakami Y, Tamai I, Kawai K. Kinetic analyses of trans-1-amino-3-18F- fluorocyclobutanecarboxylic acid transport in Xenopus laevis oocytes expressing human ASCT2 and SNAT2. Nucl Med Biol. 2013;40(5):670-5. IF=2.408
  61. Higaki Y, Kobayashi M, Uehara K, Hanaoka H, Arano Y, Kawai K. Appropriate collimators in a small animal SPECT scanner with CZT detector. Ann Nucl Med, 2013;27(3): 271-8. IF=2.668
  62. Nishi K, Kobayashi M, Nishii R, Shikano N, Takamura N, Kuga N, Yamasaki K, Nagamachi S, Tamura S, Otagiri M, Kawai K. Pharmacokinetic alteration of 99mTc-MAG3 using serum protein binding displacement method. Nucl Med Biol. 2013;40(3):366-70. IF=2.408
  63. Kobayashi M, Hashimoto F, Ohe K, Nadamura T, Nishi K, Shikano N, Nishii R, Higashi T, Okazawa H, Kawai K. Transport mechanism of 11C-labeled L- and D-methionine in human-derived tumor cells. Nucl Med Biol. 2012;39(8):1213-8. IF=2.408
  64. Fujita K, Sugiyama M, Akiyama Y, Hioki K, Kunishima M, Nishi K, Kobayashi M, Kawai K, Sasaki Y. N-Isopropyl-p-iodoamphetamine hydrochloride (IMP) is predominantly metabolized by CYP2C19. Drug Metab Dispos. 2012;40(5):843-6.IF=3.922
  65. Kobayashi M, Mori T, Kiyono Y, Tsujikawa T, Maruyama R, Higaki Y, Shikano N, Nishii R, Kawai K, Kudo T, Okazawa H. Appropriate parameters of ordered-subset expectation maximization algorithm on measurement of myocardial blood flow and oxygen consumption with 11C-Acetate. Nucl Med Commun. 2012;33(2):130-8. IF=1.690
  66. Kobayashi M, Mori T, Kiyono Y, Tiwari VN, Maruyama R, Kawai K, Okazawa H. Cerebral oxygen metabolism of rats using injectable 15O-oxygen with a steady-state method. J Cereb Blood Flow Metab. 2012;32(1):33-40. IF=6.200
  67. Nakanishi T, Fukushi A, Sato M, Shirasaka Y, Ohe K, Kobayashi M, Kawai K, Tamai I. Functional characterization of apical transporters expressed in rat proximal tubular cells (PTCs) in primary culture. Mol Pharm. 2011;8(6):2142-50. IF=3.500
  68. Martinez ME, Kiyono Y, Noriki S, Inai K, Mandap KS, Kobayashi M, Mori T, Tokunaga Y, Tiwari VN, Okazawa H, Fujibayashi Y, Ido T. New Radiosynthesis of 2-deoxy-2-　[18F]fluoroacetamido-D-glucopyranose and its evaluation as a bacterial infections imaging agent. Nucl Med Biol. 2011;38(6):807-17. IF=2.408
  69. Tsujikawa T, Tsuchida T, Imamura Y, Kobayashi M, Asahi S, Shimizu K, Tsuji K, Okazawa H, Kimura H. Kikuchi-fujimoto disease PET/CT assessment of a rare cause of cervical lymphadenopathy. Clin Nucl Med. 2011;36(8):661-4. IF=7.794
  70. Okudaira H, Shikano N, Nishii R, Miyagi T, Yoshimoto M, Kobayashi M, Ohe K, Nakanishi T, Tamai I, Namiki M, Kawai K. Putative Transport Mechanism and Intracellular Fate of Anti-18F-FACBC (Trans-1-amino-3-18F-fluorocyclobutanecarboxylic acid) in human Prostate Cancer. J Nucl Med. 2011;52(5):822-9. IF=10.057
  71. Kobayashi M, Kiyono Y, Maruyama R, Mori T, Kawai K, Okazawa H. Development of an H215O steady-state method combining a bolus and slow increasing injection with a multi-programming syringe pump. J Cereb Blood Flow Metab. 2011;31(2):527-34. IF=6.200
  72. Oyama N, Hasegawa Y, Kiyono Y, Kobayashi M, Fujibayashi Y, Ponde DE, Dence C, Welch MJ, Yokoyama O. Early response assessment in prostate carcinoma by 18F-Fluorothymidine following anticancer therapy with docetaxel using preclinical tumour models. Eur J Nucl Med Mol Imaging. 2011;38(1):81-9. IF=9.236
  73. Shikano N, Kotani T, Nakajima S, Ogura M, Nakazawa S, Sagara J, Kobayashi M, Baba T, Yamaguchi N, Kubota N, Kawai K. Radioiodinated 4-iodo-L-meta-tyrosine, a system L selective artificial amino acid: molecular design and transport characterization in Chinese hamster ovary cells (CHO-K1 cells). Nucl Med Biol. 2010;37(8):903-10. IF=2.408
  74. Isozaki M, Arai Y, Kudo T, Kiyono Y, Kobayashi M, Kubota T, Kikuta K, Okazawa H. Clinical implication and prognosis of normal baseline cerebral blood flow with impaired vascular reserve in patients with major cerebral artery occlusive disease. Ann Nucl Med. 2010;24(5):371-7. IF=2.668
  75. Shikano N, Ogura M, Sagara J, Nakajima S, Kobayashi M, Baba T, Yamaguchi N, Iwamura Y, Kubota N, Kawai K. Uptake of 3-[125I]iodo-α-methyl-l-tyrosine into colon cancer DLD-1 cells: characterization and inhibitory effect of natural amino acids and amino acid-like drugs. Nucl Med Biol. 2010;37(2):197-204. IF=2.408
  76. Shikano N, Ogura M, Okudaira H, Nakajima S, Kotani T, Kobayashi M, Nakazawa S, Baba T, Yamaguchi N, Kubota N, Iwamura Y, Kubota N, Kawai K. Stimulation of 123I-3-iodo-α-methyl-L-tyrosine in chinese hamster ovary (CHO-K1) cells by tyrosine esters. Nucl Med Biol. 2010;37(2):189-96. IF=2.408
  77. Kobayashi M, Shikano N, Nishii R, Kiyono Y, Araki H, Nishi K, Oh M, Okudaira H, Ogura M, Yoshimoto M, Okazawa H, Fujibayashi Y, Kawai K. Comparison of the transcellular transport of FDG and D-Glucose by the kidney epithelial cell line LLC-PK1. Nucl Med Commun. 2010;31(2):141-6. IF=1.690
  78. Tiwari VN, Kiyono Y, Kobayashi M, Mori T, Kudo T, Okazawa H, Fujibayashi Y. Automatic labeling method for injectable 15O-oxygen using hemoglobin-containing liposome vesicles and its application for measurement of brain oxygen consumption by PET. Nucl Med Biol. 2010;37(1):77-83. IF=2.408
  79. Tsujikawa T, Yoshida Y, Kudo T, Kiyono Y, Kurokawa T, Kobayashi M, Tsuchida T, Fujibayashi Y, Kotsuji F, Okazawa H. Functional images reflect aggressiveness of endometrial carcinoma: estrogen receptor expression combined with FDG-PET. J Nucl Med. 2009;50(10):1598-604. IF=10.057
  80. Hussain R, Tsuchida T, Kudo T, Kobayashi M, Tsujikawa T, Kiyono Y, Fujibayashi Y, Okazawa H. Vasodilatory effect of adenosine triphosphate does not change cerebral blood flow: a PET study with 15O-water. Ann Nucl Med. 2009;23(8):717-23.IF=2.668
  81. Hussain R, Kudo T, Tsujikawa T, Kobayashi M, Fujibayashi Y, Okazawa H. Validation of the calculation of the clearance rate constant (kmono) of [11C]acetate using parametric kmono image for myocardial oxidative metabolism. Nucl Med Biol. 2009;36(8):877-82. IF=2.408
  82. Kuga N, Shikano N, Takamura N, Nishii R, Yamasaki K, Kobayashi M, Nagamachi S, Tamura S, Kawai K. Competitive displacement of serum protein binding of radiopharmaceuticals with amino-acid infusion investigated with N-isopropyl-p-123I-iodoamphetamine. J Nucl Med. 2009;50(8):1378-83. IF=10.057
  83. Yoshii Y, Furukawa T, Yoshii H, Mori T, Kiyono Y, Waki A, Kobayashi M, Tsujikawa T, Kudo T, Okazawa H, Yonekura Y, Fujibayashi Y. Cytosolic acetyl-CoA synthetase affected tumor cell survival under hypoxia: the possible function in tumor acetyl-CoA/acetate metabolism. Cancer Sci. 2009;100(5):821-7. IF=6.716
  84. Oh M, Tanaka T, Kobayashi M, Furukawa T, Mori T, Fujieda S, Fujibayashi Y. Radio-cooper labeled Cu-ATSM: an indicator of quiescent but clonogenic tumor cells under mild hypoxia. Nucl Med Biol. 2009;36(4):419-26. IF=2.408
  85. Mandap KS, Ido T, Kiyono Y, Kobayashi M, Lohith TG, Mori T, Kasamatsu S, Kudo T, Okazawa H, Fujibayashi Y. Development of microwave-based automated nucleophilic [18F]fluorination system and its application for the production of [18F]flumazenil. Nucl Med Biol. 2009;36(4):403-9. IF=2.408
  86. Mori T, Sun LQ, Kobayashi M, Kiyono Y, Okazawa H, Furukawa T, Kawashima H, Welch MJ, Fujibayashi Y. Preparation and evaluation of ethyl [18F]fluoroacetate as a pro-radiotracer of [18F]fluoroacetate for the measurement of glial metabolism by PET. Nucl Med Biol. 2009;36(2):155-62. IF=2.408
  87. Lohith TG, Furukawa T, Mori T, Kobayashi M, Fujibayshi Y. Basic evaluation of FES-hERL PET tracer-reporter gene system for in vivo monitoring of adenoviral-mediated gene therapy. Mol Imaging Biol. 2008;10(5):245-52. IF=3.488
  88. Kobayashi M, Kudo T, Tsujikawa T, Isozaki M, Arai Y, Fujibayashi Y, Okazawa H. Shorter examination method for the diagnosis of misery perfusion using count-based OEF elevation in 15O-gas PET. J Nucl Med. 2008;49(2): 242-6. IF=10.057
  89. Tsujikawa T, Okazawa H, Yoshida Y, Mori T, Kobayashi M, Tsuchida T, Fujibayashi Y. Distinctive FDG and FES accumulation pattern of two tamoxifen treated patients with endometrial hyperplasia. Ann Nucl Med. 2008;22(1):73-7. IF=2.668
  90. Tsujikawa T, Ohtsuka H, Morita N, Saegusa H, Kobayashi M, Okazawa H, Nishitani H. Does partial volume corrected maximum SUV based on count recovery coefficient in 3D-PET/CT correlate with clinical aggressiveness of non-Hodgkin lymphoma? Ann Nucl Med. 2008;22(1):23-30. IF=2.668
  91. Tsuchida T, Okazawa H, Mori T, Kobayashi M, Yoshida Y, Fujibayashi Y, Itoh H. In vivo imaging of estrogen receptor concentration in the endometrium and myometrium using FES PET-influence of menstrual cycle and endogenous estrogen level. Nucl Med Biol. 2007;34(2):205-10. IF=2.408
  92. Okazawa H, Tsuchida T, Kobayashi M, Arai Y, Pagani M, Isozaki M, Yonekura Y. Can reductions in baseline CBF and vasoreactivity detect misery perfusion in chronic cerebrovascular disease? Eur J Nucl Med Mol Imaging. 2007;34(1):121-9. IF=9.236
  93. Kobayashi M, Okazawa H, Tsuchida T, Kawai K, Fujibayashi Y, Yonekura Y. Diagnosis of misery perfusion using noninvasive O-15 gas PET. J Nucl Med. 2006;47(10):1581-6. IF=10.057
  94. Okazawa H, Tsuchida T, Pagani M, Mori T, Kobayashi M, Tanaka F, Yonekura Y. Effects of 5-HT1B/1D receptor agonist rizatriptan on cerebral blood flow and blood volume in normal circulation. J Cereb Blood Flow Metab. 2006;26(1):92-8. IF=6.200

2．査読有の和文学術論文 （計4編，うち筆頭2編）

  1. 浦井珠恵，松本勝，井内映美，小林正和，西村誠次，須釜淳子．エアマットレス使用時の枕のあて方が上肢・胸部の筋の硬さと自覚症状に及ぼす影響．Journal of Wellness and Health Care. 2018;41(2):151-8.
  2. 小林正和，田中利恵，松原孝祐，森岡茂晃，辻岡勝美，有村秀孝，上田克彦，小倉明夫，宮地利明．日本放射線技術学会の海外派遣事業における派遣者の動向及び業績の調査 日本放射線技術学会雑誌. 2017;73(10):1061-5.
  3. 小林正和, 杉本勝也, 丸山力哉, 工藤崇, 辻川哲也, 清野泰, 小野口昌久, 川井恵一, 藤林靖久, 岡沢秀彦. 18F-FDGを用いた脳PET検査の健常者データベースにおけるTransmission撮像および減弱補正法の影響. 日本放射線技術学会雑誌. 2010;66(1):42-8.
  4. 辻川哲也, 吉田好雄, 工藤崇, 清野泰, 黒川哲司, 小林正和, 土田龍郎, 藤林靖久, 岡沢秀彦. 子宮腫瘍性疾患におけるエストロゲン受容体とブドウ糖代謝の関連. 臨床放射線. 2008;53(10):1238-43.

3．査読無の学術論文 （計3編，うち筆頭1編）

  1. 小林正和．教育講座：放射線技術学を用いた先端生命科学研究－前臨床における腫瘍核医学イメージング－．放射線技術学会雑誌. 2018;74(12):1458-61．
  2. 岡沢秀彦，清野泰，Tiwari VN，森哲也，小林正和，藤林靖久．人工赤血球を用いた脳酸素代謝測定．人工血液.2010;18(3):97-101.
  3. 岡沢秀彦, 小林正和, 辻川哲也, 工藤崇, 清野泰, 藤林康久, Lohith TG, Tiwari VN．脳卒中治療に関連した分子プローブの開発と臨床応用の可能性．脳卒中. 2008;30(6):817-21.


PAGE TOP